Skip to main content
. 2002 Dec;46(12):3947–3953. doi: 10.1128/AAC.46.12.3947-3953.2002

TABLE 4.

Relationship between the number of mutations in the Pvdhfr gene and clinical outcome following treatment of vivax malaria with an SP-containing regimen

No. of mutations No. (%) of isolatesa No. (%) of isolates with ACPR with SP-containing regimen
0 6 (21) 4/5 (83)
1 3 (11) 2/2 (100)
2 13 (46) 9/9 (100)
3 1 (4) b
4 5 (18) 2/5 (40)
Total 28
a

Includes isolates from patients with mixed infections.

b

—, not treated with SP-containing regimen.